Abstract
Medical therapy of IBD has made remarkable progress in recent years, driven forward by new knowledge about mechanisms of disease and advances in biotechnology. As we continue to learn about how best to use the agents currently in our hands, the addition of new drugs will further improve outcomes, and will bring new insights into the fundamental causes of these diseases.
Original language | English |
---|---|
Pages (from-to) | 1045-1064 |
Number of pages | 20 |
Journal | Surgical Clinics of North America |
Volume | 86 |
Issue number | 4 |
DOIs | |
State | Published - Aug 2006 |
Externally published | Yes |